Veerhealth Care Ltd — Important, 16-02-2026: Company Update

Veerhealth Care announced its financial results for the quarter and nine months, reporting robust growth. Total Income grew 73.13% YoY to 6.96 Cr, while Net Profit (PAT) surged 474.18% YoY to 0.40 Cr. The company secured US FDA clearance for Drug (OTC) products and completed USFDA formalities for medical devices, boosting export potential to the USA and other international markets. New production facilities and expanded e-commerce presence also aim to drive growth. Management anticipates FY27 revenues of 45-50 Cr (7-10% PAT) and 100 Cr revenue within 24 months (10% PAT).